ONCOLOGY PHARMA
Oncology Pharma engages in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
ONCOLOGY PHARMA
Industry:
Medical Therapeutics
Founded:
1993-01-01
Status:
Active
Contact:
(415) 869-1036
Email Addresses:
[email protected]
Total Funding:
38.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Wix Fastly Hosted Fastly Load Balancer
Similar Organizations
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Stock Details
Company's stock symbol is OTCPINK:ONPH
Investors List
SCP Partners
SCP Partners investment in Post-IPO Debt - Oncology Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-12-11 | Diagnomics | Oncology Pharma investment in Corporate Round - Diagnomics | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-01-28 | Oncology Pharma Announces the Appointment Of New Chief Financial Officer |